Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Cognitive Neuropsychiatry|March 11, 2006
Configural processing in face recognition in schizophreniaBarbara L Schwartz, Cherie L Marvel, Amy Drapalski, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 5, 2008
Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonistPin-Yu Perera, Jack H Lichy, John Mastropaolo, et al.
European Journal of Pharmacology|August 7, 2002
Topiramate antagonizes MK-801 in an animal model of schizophreniaStephen I Deutsch, Richard B Rosse, Eddie N Billingslea, et al.
Clinical Neuropharmacology|April 3, 2003
Methyllycaconitine fails to inhibit electrically precipitated tonic hindlimb extension in miceStephen I Deutsch, Richard B Rosse, Alan S Bellack, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 22, 2009
NMDA NR2B subtype-selective receptor antagonists fail to antagonize electrically-precipitated seizures and elicit popping in miceJessica A Burket, John Mastropaolo, Richard B Rosse, et al.
Life Sciences|August 28, 2003
Modulation of MK-801-elicited mouse popping behavior by galantamine is complex and dose-dependentStephen I Deutsch, Richard B Rosse, Eddie N Billingslea, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 7, 2007
Guanosine possesses specific modulatory effects on NMDA receptor-mediated neurotransmission in intact miceStephen I Deutsch, Richard B Rosse, Katrice D Long, et al.
Clinical Neuropharmacology|April 3, 2008
Epigenetic therapeutic strategies for the treatment of neuropsychiatric disorders: ready for prime time?Stephen I Deutsch, Richard B Rosse, John Mastropaolo, et al.
Pageof 5